NCT07272096

Brief Summary

The goal of this clinical trial is to test whether a single-session Acceptance and Commitment Therapy (ACT) videogame (ACTing Minds) improves psychological flexibility and mental health in adults who report mild to moderate depression, anxiety or stress. The main questions are whether ACTing Minds increases psychological flexibility (CompACT Total) more than a time- and engagement-matched neutral commercial game at the end of the session and again at short-term follow-up (10-13 days), and whether it produces favourable changes in symptoms, wellbeing, social connectedness, health-related quality of life, and short seated heart-rate variability recordings. Researchers will compare ACTing Minds with the neutral game to determine whether the ACT-based experience leads to greater improvements. Participants attend one laboratory visit of about 60 minutes, complete brief questionnaires at baseline, immediately after the session and at short-term follow-up, and provide a short seated ECG at each timepoint for heart-rate variability analysis. The study uses a single-blind, two-arm, randomised, parallel-group design at Swansea University (UK).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
302

participants targeted

Target at P75+ for not_applicable depression

Timeline
Completed

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

November 26, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 9, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2025

Completed
Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

13 days

First QC Date

November 14, 2025

Last Update Submit

February 9, 2026

Conditions

Keywords

Acceptance and Commitment TherapyACTPsychological flexibilityDigital mental healthSerious gameVideogame interventionSingle-session interventionRandomised controlled trialCompACTDASS-21Flourishing ScaleSocial Connectedness ScaleEQ-5DHeart rate variabilityHRVECG

Outcome Measures

Primary Outcomes (2)

  • Psychological flexibility (CompACT Total)

    CompACT total score; higher scores indicate greater psychological flexibility. Primary estimand is the between-group difference in change from baseline to short-term follow-up (10-13 days post-intervention); post-session estimates will also be reported.

    Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); short-term follow-up (10-13 days post-intervention).

  • Mental-health symptoms (DASS-21 Total)

    DASS-21 total score; higher scores indicate greater symptom severity.

    Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).

Secondary Outcomes (13)

  • Depressive symptoms (DASS-21 Depression)

    Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).

  • Anxiety symptoms (DASS-21 Anxiety)

    Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).

  • Stress symptoms (DASS-21 Stress)

    Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).

  • Wellbeing (Flourishing Scale)

    Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).

  • Social connectedness (Social Connectedness Scale)

    Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).

  • +8 more secondary outcomes

Study Arms (2)

ACTing Minds (ACT videogame)

EXPERIMENTAL

Single \~60-minute session on a study-supplied smartphone in the lab; assessments at baseline, post-session, and short-term follow-up (10-13 days post-intervention).

Behavioral: ACTing Minds (ACT videogame)

Neutral commercial puzzle game (Monument Valley)

ACTIVE COMPARATOR

Engagement- and time-matched \~60-minute smartphone session in the lab; assessments at baseline, post-session, and short-term follow-up (10-13 days post-intervention).

Behavioral: Monument Valley (mobile; neutral control)

Interventions

Single-session (\~60 min) ACT-based videogame integrating acceptance/openness, cognitive defusion, present-moment awareness, values and values-guided action via structured chapters. Delivered on a study-supplied Samsung Galaxy S9+ (Android) under standardised instructions; no therapist guidance during play.

ACTing Minds (ACT videogame)

Commercial mobile puzzle game used as an engagement- and time-matched control (\~60 min) with no therapeutic content. Delivered on a study-supplied Samsung Galaxy S9+ (Android) in the lab. Title/version fixed for the trial; procedures and environment identical to the experimental arm. No data are collected within the app.

Neutral commercial puzzle game (Monument Valley)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Able to read and understand English
  • Self-reported mild to moderate symptoms of depression, anxiety, or stress
  • Provides written informed consent
  • Willing and able to attend one \~60-minute laboratory session and complete online follow-up questionnaires 10-13 days later
  • Agrees to ECG recording (seated \~5 minutes at each timepoint)
  • Willing to play either study videogame on a study-supplied Samsung Galaxy S9+ (Android)

You may not qualify if:

  • Current or past severe mental illness (e.g., psychotic disorder, bipolar disorder)
  • Current psychotropic medication use (e.g., antidepressants, anxiolytics, antipsychotics, mood stabilisers, stimulants)
  • Concurrent psychological therapy (any modality)
  • Pregnancy
  • Cardiovascular conditions or clinically significant arrhythmias that could affect ECG or HRV measurement or be exacerbated by study procedures
  • Implanted cardiac devices (e.g., pacemaker or ICD)
  • Any neurological condition, medical condition, or skin condition that would preclude safe ECG electrode placement or comfortable seated recording
  • Insufficient English proficiency to provide informed consent or complete study measures
  • Any other factor that, in the judgement of the investigators, would compromise safety, data quality, or protocol compliance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Swansea University, School of Psychology (Singleton Park)

Swansea, Wales, SA2 8PP, United Kingdom

Location

Related Publications (2)

  • Edwards DJ, Kemp AH. A novel ACT-based video game to support mental health through embedded learning: a mixed-methods feasibility study protocol. BMJ Open. 2020 Nov 16;10(11):e041667. doi: 10.1136/bmjopen-2020-041667.

    PMID: 33199427BACKGROUND
  • Gordon TC, Kemp AH, Edwards DJ. Mixed-methods feasibility outcomes for a novel ACT-based video game 'ACTing Minds' to support mental health. BMJ Open. 2024 Mar 29;14(3):e080972. doi: 10.1136/bmjopen-2023-080972.

    PMID: 38553053BACKGROUND

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Officials

  • Darren J Edwards, PhD

    Swansea University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants masked to allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two-arm, 1:1 randomised, single-session, laboratory-based trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 14, 2025

First Posted

December 9, 2025

Study Start

November 26, 2025

Primary Completion

December 9, 2025

Study Completion

December 9, 2025

Last Updated

February 12, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

We will share de-identified individual participant data (IPD) underlying the published results, including all questionnaire outcomes (CompACT total/subscales, DASS-21 total/subscales, Flourishing, Social Connectedness, EQ-5D index and VAS), heart-rate variability summary indices (lnRMSSD, lnSDNN, lnHF, lnLF, lnLF/HF) and mean heart rate at T1-T3, allocation group, age band and gender. A data dictionary, statistical analysis plan and analysis code will be provided. Raw ECG waveforms and any free-text fields will not be shared. Data will be deposited on the Open Science Framework and released at article acceptance/publication; access will be open (no application) under an appropriate licence.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Data and documents will be made available at article acceptance/publication. If journal processes impose a brief embargo, release will occur within 3 months of acceptance. Materials will be retained indefinitely with versioning; any material updates (e.g., errata, code revisions) will be posted to the same repository. The registry will be updated with the dataset DOI/URL on release.
Access Criteria
Open access: no application required. De-identified IPD (questionnaire outcomes, HRV summary indices, mean heart rate, allocation group, age band, gender), data dictionary, SAP, protocol, consent template, and analysis code will be downloadable from a public repository.

Locations